Questions? We're here to help. Health advisors on staff. Call us toll-free at (866) 947-6789.

What Makes Neo40 So Unique?


Dr. Nathan Bryan – Video Transcription

What makes Neo40 unique?

This technology we developed does two things: It generates authentic nitric oxide gas, and then number two, it restores the enzyme that makes nitric oxide in the human body, in the lining of the blood vessels. We give the people a source of nitric oxide that otherwise they can't make, but we really get to the root cause of why they can't make nitric oxide. Over time, we improve their own ability to generate nitric oxide.

Why are you passionate nitric oxide?

Well I spent my entire academic career studying a single molecule called nitric oxide. Over the course of those 15 years, we've learned a lot in the study of nitric oxide. One, we know it's probably one of the most important molecules produced in the human body. Two, we know that as we age, we lose the ability to generate nitric oxide. Throughout this 15 years of research, we've figured out what goes wrong in patients that can't make nitric oxide. Perhaps most importantly, how to fix this underlying problem. It truly is to change the world. I think a lot of people use that phrase, but we see this every day, and it's been said you change the life of one person, you've changed the world, certainly changed their world.

When we get a number of emails and dozens, if not hundreds, of emails and phone calls every week, every month of people telling us that we've changed their lives. When I say we want to change the world, I think that's not beyond our reach. I think we can do it. People understand the importance of nitric oxide and then understand that we know how to make nitric oxide.

How does Neo40 compare to L-arginine?

When we formed this company back in 2010, there were a number of nitric oxide products on the market, dating back to 1998. After the Nobel Prize was awarded, it was recognized that L-arginine could actually be utilized to make nitric oxide. A number of products hit the market, L-arginine based. They talked about a nitric oxide story. What we've discovered over the years is that people are nitric oxide deficient, because they've lost the ability to convert arginine to nitric oxide. Giving L-arginine to a nitric oxide deficient patient, like putting gas in a car with a blown up engine. You have to fix the engine. 99% of the other companies out there, who market a nitric oxide product are typically L-arginine based. There's some serious limitations to those products and those technologies. The good thing is they've helped educate the market for us. The bad thing is that they've trivialized the effect of nitric oxide. It's not just a pre-workout pump, and increase in blood flow, and vascularity.

What we do and what separates us, is obviously we generate authentic nitric oxide gas and we fix the engine I talked about. The body's own ability to make nitric oxide is improved.

The other thing we do because of my issued patents, and the relationship we have with the University of Texas Medical School in Houston, we're obligated to test if people are infringing on our patents. Any nitric oxide product out there, we put to the test. We test to see if it generates nitric oxide, if it activates endogenous nitric oxide production, and then we keep that on file. There's not any product out there, despite the dozens, if not hundreds of products, of nitric oxide products on the market - food or supplement - that do what our technology does.

Related Reads:

Say Yes to NO, the Miracle Molecule

Axioma Health – What is Nitric Oxide?


Health Disclaimer. Copyright ©2017. Published with permission. Dr. Nathan Bryan is a professor of molecular medicine at the University of Texas Health Science Center at Houston. He is a leading expert on nitric oxide biochemistry and physiology and has published over sixty papers, and written four books on the subject. He is also an inventor on three issued US patents on five pending worldwide. Dr. Bryan is co-founder and Chief Science Officer of Neogenis Labs, Inc.